ArticleBMC infectious diseases2026
Extending prophylactic antimicrobial use beyond 48 h postoperatively fails to reduce surgical site infections and other healthcare-associated infections in patients undergoing colorectal resection: a Propensity Score Matching study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt is controversial whether antibiotic should be used prophylactically 48 h after colorectal resection. Hence, the association of prophylactic antimicrobial (PA) use beyond 48 h postoperatively with the incidence of surgical site infections (SSI) and other healthcare-associated infections (HAI) in patients receiving colorectal resection surgery was evaluated.
methodsA retrospective analysis was performed on 2691 patients who underwent colorectal resection between March 1, 2023, and December 31, 2025. Patients were categorized into the non-PA beyond 48 h postoperatively group (n = 1934) and the PA beyond 48 h postoperatively group (n = 757) based on whether prophylactic antibiotic use exceeded 48 h postoperatively. Propensity Score Matching (PSM) was used to balance differences in covariates between the two groups, subsequently, the relationship between prophylactic antibiotic use and infection was analyzed.
resultsThe incidence of surgical site infections (SSI) in patients undergoing colorectal resection was 8.51% (229/2691), while the incidence of other healthcare-associated infections (HAI) was 8.06% (217/2691). After PSM, both non-PA beyond 48 h postoperatively group and PA beyond 48 h postoperatively group were divided into 757 cases each. Multiple regression analysis showed that PA beyond 48 h postoperatively was not associated with SSI(OR = 0.85, 95% CI 0.59 -1.21, P = 0.356) and other HAI (OR = 0.81, 95% CI 0.54-1.23, P = 0.325) after adjustment for the confounding effect of age, sex, diabetes, hypertension, anemia, hypoproteinemia. Subsequent to adjustment for all confounding factors, PA beyond 48 h postoperatively was still not a influence factor for SSI (OR = 0.85, 95% CI 0.59-1.22, P = 0.372) and other HAI (OR = 0.77, 95% CI 0.50-1.18, P = 0.229). The total cost (¥57349.60 vs. ¥55039.10, P = 0.0006) were higher in the PA beyond 48 h postoperatively group than non-PA beyond 48 h postoperatively group, and no statistically significant differences were observed between the two groups in postoperative hospital stay (P > 0.05).
conclusionExtending prophylactic antimicrobial use beyond 48 h postoperatively following colorectal resection surgery was not associated with lower morbidity rate of SSI and other HAI, nor did it shorten the postoperative hospital stay; however, it resulted in elevated costs. Nonetheless, this study may contribute to the development of strategies for standardizing prophylactic medication management during the perioperative period of colorectal resection. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
42894129What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.